資源描述：
《蛭龍活血通瘀膠囊治療后循環(huán)缺血性眩暈療效觀察》由會(huì)員上傳分享，免費(fèi)在線閱讀，更多相關(guān)內(nèi)容在工程資料-天天文庫。
1、姪龍活血通瘀膠囊治療后循環(huán)缺血性眩暈療效觀察李凌華，楊思進(jìn)(通訊作者)(四川醫(yī)科大學(xué)，四川瀘州，646000)［摘要］目的：觀察蛭龍活血通瘀膠囊治療后循環(huán)缺血性眩暈的臨床療效。方法：將90例后循環(huán)缺血性眩暈患者隨機(jī)分為治療組與對照組各45例，對照組給予鹽酸氟桂利嗪膠囊治療，治療組在對照組治療基礎(chǔ)上加用蛭龍活血通瘀膠囊治療。比較兩組的臨床療效、中醫(yī)癥狀積分、超敏C反應(yīng)蛋白(hs-CRP)、椎基底平均血流速度(Vm)的變化情況。結(jié)果：觀察組總有效率明顯優(yōu)于對照組(P<0.05))，說明蛭龍活血通瘀膠囊結(jié)合丙藥治療后循環(huán)缺血性眩暈的臨床療效優(yōu)于單純丙藥治療
2、；中醫(yī)癥狀積分兩組均有改善，但觀察組優(yōu)于對照組(P<0.05)；兩組治療后hs-CRP均下降，與木組治療前相比，差異均有統(tǒng)計(jì)學(xué)意義(P<0.05)，組間比較，治療組的改善更為明顯，差異具有統(tǒng)計(jì)學(xué)意義(P<0.05)說明蛭龍活血通瘀膠囊能降低患者的hs-CRP水平，對于預(yù)防動(dòng)脈粥樣硬化爲(wèi)有重要意義；兩組治療后椎基底動(dòng)脈血流速度均有改善，但觀察組椎動(dòng)脈及基底動(dòng)脈較對照組改善明顯(P<0.05),說明蛭龍活血通瘀膠囊在改善腦部供血方面具有較好的療效。結(jié)論：蛭龍活血通瘀膠囊治療后循環(huán)缺血性眩暈在改善患者癥狀、預(yù)防動(dòng)脈粥樣硬化、改善腦血流狀況
3、方面均有較好的療效。［關(guān)鍵詞］后循環(huán)缺血：眩暈：蛭龍活血通瘀膠囊ZhilongHuoxueTongyucapsuletreatmentofPosteriorcirculationischemicvertigoClinicalobservationLILing-Hua,YANGSi-Jin(SichuanMedicalUniversity,Luzhou,Sichuan,646000)Abstract:Objective:ToobservetheclinicalcurativeeffectofzhilonghuoxueTongyucapsuleinthetre
4、atmentofposteriorcirculationischemicvertigo.Methods:Atotalof90withposteriorcirculationischemiavertigowereequallyandrandomlydividedintotreatmentgroupandcontrolgroup,ThecontrolgroupwasgivenFlunarizineHydrochlorideCapsulestreatment,thetreatmentgroupinthecontrolgrouptreatedwithzhilong
5、HuoxueTongyucapsuletreatment.Theclinicaleffectofthetwogroups,thesymptomintegralofTCM,theultrasensitiveCreactiveprotein(hs-CRP),andthemeanbloodflowvelocity(Vm)ofthevertebralbodywerecompared.Results:thetotaleffectiverateofobservationgroupwassignificantlybetterthanthecontrolgroup(P&l
6、t;0.05)),indicatingclinicalcurativeeffectisbetterthanpurewesternmedicineinthetreatmentofzhilonghuoxueTongyucapsulecombinedwithwesternmedicineinthetreatmentofposteriorcirculationischemicvertigo;TCMsymptomscoresofthetwogroupswereallimproved,buttheobservationgroupthanthecontrolgroup(
7、P<0.05);thetwogroupsaftertreatmentdecreasedhs-CRP,comparedwiththegroupbeforetreatment,thedifferenceswerestatisticallysignificant(P<0.05),comparisonbetweengroups,thetreatmentgroupimprovedmoresignificantly,thedifferencewasstatisticallysignificant(P<0.05)thatzhilonghuoxueTon
8、gyucapsulecandecreasethehs-CRPlev
